MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
about
Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic interventionMolecular pathogenesis of multiple myeloma: basic and clinical updatesNovel therapeutic strategies for multiple myelomaDifferential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.MicroRNA: important player in the pathobiology of multiple myelomaMMSET: role and therapeutic opportunities in multiple myeloma.Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationThe ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA.The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapyOxidative stress response and Nrf2 signaling in aging.Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.Mind the methyl: methyllysine binding proteins in epigenetic regulation.Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.The NSD family of protein methyltransferases in human cancer.Epigenetic modifiers in normal and malignant hematopoiesis.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.Histone Modifications and Cancer.MicroRNA expression profiling defines the impact of electronic cigarettes on human airway epithelial cells.H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor developmentMicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma.The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.Gene Expression Profiles in Myeloma: Ready for the Real World?UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma.miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.The biological significance of histone modifiers in multiple myeloma: clinical applications
P2860
Q27024233-9B83F314-1CB1-4EBE-945D-154F4286D21CQ27026205-4C952FAF-AFDF-43E9-90F4-8680FBFBD36EQ28081590-CCFDA318-F9AA-42CB-8B0D-03C9C68550CDQ33682993-294492AB-0BC3-4529-BEAA-17D50A95A043Q33786861-2580EC76-F335-4D83-BAA7-44DF238A27ACQ33908640-2CB83D80-A0B2-43AB-86B3-4A1119FEF7E2Q34133622-24C0BB4B-2A9F-4CAA-8880-15A477C255C5Q35656801-2C17FD34-0C98-4B14-905C-8AD940436085Q36169794-0FACE16A-5804-4E88-823F-5305B97B7D3DQ36236785-3073BC84-5E54-48AC-8927-0109F3F48174Q36413501-005C68C2-0B6D-4851-BCE0-0942A795830AQ38180674-4C8C8911-10CE-4FDF-BFC2-AFA5BBDC22DDQ38190971-9FA45F53-E030-4FE3-B917-077F75E1EE65Q38459795-06FA7159-51FD-4793-89CC-301FB5AEACE6Q38459868-EACE57AF-FD43-4FF6-92F4-FCDEB050E0E1Q38476564-863E4488-E5A9-4737-A51E-4C5E6AC1E16BQ38796064-A621CB36-31FA-44DF-9277-49F4D0878B89Q38821943-30EF38CA-56C6-4E53-ABA0-E17800AF9E02Q38829055-00D15D4B-7383-4DB8-86CE-1F93D166319CQ39084498-83D30403-75FC-4252-A403-748AF51C99BDQ39134084-9003F29F-1DFF-47FE-8C5C-E57B45F50C2CQ39379624-25E16CD3-7DB0-4466-8737-29FD0F3DBD34Q40928974-94EA84B3-1CF0-42B3-B2A4-50F8B02931E7Q42084832-51FC9B7A-D9D1-4A0D-AA00-0DEE3EACA334Q43847809-517AD7C0-8190-4254-8193-46A416B7EA51Q47098704-BA781E60-3597-4DC1-B3D5-DB592E83E9D8Q47149175-5A138A0F-BC8B-4ACA-B52E-81D36E4523FEQ51358936-02635F7F-9056-414C-A482-5C2BB029DC0DQ55313036-67485FDB-3D3C-4129-B4B1-1233CA00CF8DQ55342254-D2CC3C76-80BE-467B-807F-D978CAB85218Q58718492-F2EAA3EB-D4E0-4EB2-AB66-3DA299E1045A
P2860
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
@en
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
@nl
type
label
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
@en
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
@nl
prefLabel
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
@en
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
@nl
P2093
P2860
P356
P1433
P1476
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC
@en
P2093
E Martinez-Garcia
P2860
P2888
P304
P356
10.1038/LEU.2012.269
P577
2012-09-13T00:00:00Z